» Articles » PMID: 6722789

Sensitivity of Human Cell Strains Having Different Abilities to Repair O6-methylguanine in DNA to Inactivation by Alkylating Agents Including Chloroethylnitrosoureas

Overview
Journal Cancer Res
Specialty Oncology
Date 1984 Jun 1
PMID 6722789
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

In order to investigate the mechanisms of cellular damage by alkylating agents, human fibroblasts and tumor cell strains having different sensitivities to killing by N-methyl-N'-nitro-N-nitrosoguanidine [and different abilities to repair O6-methylguanine ( O6mGua ) in their DNA] were treated with other alkylating agents. Methyl methanesulfonate, 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), 1-(2-hydroxyethyl)-3-(2-chloroethyl)-3-nitrosourea, and N-ethyl-N'-nitro-N-nitrosoguanidine gave rise to sensitivity differences, but the differences were less than those observed with N-methyl-N'-nitro-N-nitrosoguanidine. After treatment with UV light, the strains showed similar survival. The data show that the DNA repair mechanism(s) responsible for the differential survival of the strains after N-methyl-N'-nitro-N-nitrosoguanidine treatment probably play(s) a role in repairing DNA damage produced by methyl methanesulfonate, N-ethyl-N'-nitro-N-nitrosoguanidine, BCNU, and 1-(2-hydroxyethyl)-3-(2-chloroethyl)-3-nitrosourea but not that produced by UV. Furthermore, the results support the idea that a breakdown product of BCNU, that does not cause damage repairable by O6mGua repair mechanisms, contributes to the lethal effects due to BCNU-produced DNA-damage that is repairable by O6mGua repair mechanisms. The survival data, along with nucleoid sedimentation and adenovirus host-cell reactivation data, are consistent with the hypothesis that the lesion(s) lethal to tumor cells defective in O6mGua DNA repair are lesions in which DNA oxygen atoms are alkylated.

Citing Articles

Preclinical pharmacology of the antitumor agent O-6-methylguanine in CDF1 mice.

Avramis V, Chan K, Solorzano M, Chen Z Cancer Chemother Pharmacol. 1993; 33(3):197-202.

PMID: 8269600 DOI: 10.1007/BF00686216.


Antitumor alkylating agents: in vitro cross-resistance and collateral sensitivity studies.

Frei 3rd E, Holden S, GONIN R, Waxman D, Teicher B Cancer Chemother Pharmacol. 1993; 33(2):113-22.

PMID: 8261570 DOI: 10.1007/BF00685328.


Characterization and chemosensitivity of two cell lines derived from human glioblastomas.

Izumu I, Mineura K, Watanabe K, Kowada M J Neurooncol. 1993; 17(2):111-21.

PMID: 8145054 DOI: 10.1007/BF01050213.


Potential of O6-methylguanine or O6-benzylguanine in the enhancement of chloroethylnitrosourea cytotoxicity on brain tumours.

Mineura K, Izumi I, Watanabe K, Kowada M, Kohda K, Ikenaga M Acta Neurochir (Wien). 1994; 128(1-4):13-20.

PMID: 7847129 DOI: 10.1007/BF01400647.


O6-methylguanine-DNA methyltransferase activities in biopsies of human melanoma tumours.

Egyhazi S, Hansson J, Ringborg U Br J Cancer. 1995; 71(1):37-9.

PMID: 7819045 PMC: 2033437. DOI: 10.1038/bjc.1995.8.